These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 12447672

  • 1. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.
    Yoshizawa K, Nagai H, Sakurai S, Hironaka M, Morinaga S, Saitoh K, Fukayama M.
    Virchows Arch; 2002 Nov; 441(5):437-43. PubMed ID: 12447672
    [Abstract] [Full Text] [Related]

  • 2. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
    Wada K.
    J Hepatobiliary Pancreat Surg; 2002 Nov; 9(1):76-85. PubMed ID: 12021900
    [Abstract] [Full Text] [Related]

  • 3. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.
    Izawa T, Obara T, Tanno S, Mizukami Y, Yanagawa N, Kohgo Y.
    Cancer; 2001 Oct 01; 92(7):1807-17. PubMed ID: 11745253
    [Abstract] [Full Text] [Related]

  • 4. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas.
    Schoedel KE, Finkelstein SD, Ohori NP.
    Diagn Cytopathol; 2006 Sep 01; 34(9):605-8. PubMed ID: 16900481
    [Abstract] [Full Text] [Related]

  • 5. Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.
    Nakata B, Yashiro M, Nishioka N, Aya M, Yamada S, Takenaka C, Ohira M, Ishikawa T, Nishino H, Wakasa K, Hirakawa K.
    Int J Oncol; 2002 Nov 01; 21(5):1067-72. PubMed ID: 12370756
    [Abstract] [Full Text] [Related]

  • 6. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K, Hiyama E, Murakami Y, Kanehiro T, Ohge H, Sueda T, Yokoyama T.
    Oncol Rep; 2003 Nov 01; 10(2):277-83. PubMed ID: 12579258
    [Abstract] [Full Text] [Related]

  • 7. Single-pattern convergence of K-ras mutation correlates with surgical indication of intraductal papillary mucinous neoplasms.
    Mizuno O, Kawamoto H, Yamamoto N, Horiguchi S, Tsutsumi K, Fujii M, Kato H, Hirao K, Kurihara N, Ishida E, Ogawa T, Okada H, Yamamoto K.
    Pancreas; 2010 Jul 01; 39(5):617-21. PubMed ID: 20173673
    [Abstract] [Full Text] [Related]

  • 8. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J, Schlehe B, Menke MA, Vogel I, Henne-Bruns D, Klöppel G.
    Cancer; 1999 Apr 15; 85(8):1703-10. PubMed ID: 10223563
    [Abstract] [Full Text] [Related]

  • 9. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.
    Jang JY, Park YC, Song YS, Lee SE, Hwang DW, Lim CS, Lee HE, Kim WH, Kim SW.
    J Hepatobiliary Pancreat Surg; 2009 Apr 15; 16(5):668-74. PubMed ID: 19412570
    [Abstract] [Full Text] [Related]

  • 10. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
    Soldini D, Gugger M, Burckhardt E, Kappeler A, Laissue JA, Mazzucchelli L.
    J Pathol; 2003 Apr 15; 199(4):453-61. PubMed ID: 12635136
    [Abstract] [Full Text] [Related]

  • 11. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS, Orlandini S, Zamboni G, Capelli P, Rigaud G, Falconi M, Bassi C, Lemoine NR, Scarpa A.
    Br J Cancer; 2001 Jan 15; 84(2):253-62. PubMed ID: 11161385
    [Abstract] [Full Text] [Related]

  • 12. Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas.
    Kitago M, Ueda M, Aiura K, Suzuki K, Hoshimoto S, Takahashi S, Mukai M, Kitajima M.
    Int J Cancer; 2004 Jun 10; 110(2):177-82. PubMed ID: 15069678
    [Abstract] [Full Text] [Related]

  • 13. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
    Mueller J, Gansauge S, Mattfeldt T.
    Hepatogastroenterology; 2003 Jun 10; 50(50):541-4. PubMed ID: 12749268
    [Abstract] [Full Text] [Related]

  • 14. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas.
    Raimondo M, Tachibana I, Urrutia R, Burgart LJ, DiMagno EP.
    Am J Gastroenterol; 2002 Oct 10; 97(10):2553-8. PubMed ID: 12385438
    [Abstract] [Full Text] [Related]

  • 15. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV, Basturk O, Cheng JD, Andea AA.
    Semin Radiat Oncol; 2005 Oct 10; 15(4):254-64. PubMed ID: 16183479
    [Abstract] [Full Text] [Related]

  • 16. Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms.
    Kobayashi N, Inamori M, Fujita K, Fujisawa T, Fujisawa N, Takahashi H, Yoneda M, Abe Y, Kawamura H, Shimamura T, Kirikoshi H, Kubota K, Sakaguchi T, Saito S, Saubermann LJ, Nakajima A.
    J Hepatobiliary Pancreat Surg; 2008 Oct 10; 15(2):169-77. PubMed ID: 18392710
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical analysis of molecular biological factors in intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Tanaka M, Manabe T.
    Scand J Gastroenterol; 2004 Nov 10; 39(11):1159-65. PubMed ID: 15545177
    [Abstract] [Full Text] [Related]

  • 18. Intraductal papillary-mucinous tumors of the pancreas.
    Kubosawa H, Uehara T, Watanabe Y, Urashima T, Matsubara H, Asano T, Ochiai T.
    Hepatogastroenterology; 2004 Nov 10; 51(59):1489-94. PubMed ID: 15362784
    [Abstract] [Full Text] [Related]

  • 19. Pancreatic mucinous cystic neoplasms with sarcomatous stroma: molecular evidence for monoclonal origin with subsequent divergence of the epithelial and sarcomatous components.
    van den Berg W, Tascilar M, Offerhaus GJ, Albores-Saavedra J, Wenig BM, Hruban RH, Gabrielson E.
    Mod Pathol; 2000 Jan 10; 13(1):86-91. PubMed ID: 10658914
    [Abstract] [Full Text] [Related]

  • 20. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
    Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB.
    Cancer; 2006 Jun 25; 108(3):163-73. PubMed ID: 16550572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.